# Intensity Therapeutics, Inc.: filings

INTS · Nasdaq · CIK 1567264 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ints.md) · [Financials](/companies/ints/financials.md) · [Filings](/companies/ints/filings.md) · [Insiders](/companies/ints/insiders.md)

## Reports and events: 83 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 45, CORRESP 38, 4 33, S-1/A 17, UPLOAD 15, FWP 12, 10-Q 10, 424B5 9, 3 8, EFFECT 5, S-8 5, SEC STAFF LETTER 5, DEF 14A 4, DEFA14A 4, 10-K 3, ARS 3, D 3, S-1 3, SCHEDULE 13G/A 3, 424B4 2, D/A 2, DRS 2, S-3 2, SC 13G 2, SCHEDULE 13G 2, 10-Q/A 1, 424B3 1, 8-A12B 1, 8-A12B/A 1, CERT 1, PRE 14A 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 07:40 ET | [8-K](/filings/0001567264-26-000061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-26-000061 |
| 2026-08-11 | 07:17 ET | [10-Q](/filings/0001567264-26-000059.md) | Quarterly report, period 2026-06-30 | 0001567264-26-000059 |
| 2026-06-16 | 16:15 ET | [8-K](/filings/0001567264-26-000049.md) | 5.07 Shareholder vote results | 0001567264-26-000049 |
| 2026-05-07 | 16:10 ET | [8-K](/filings/0001567264-26-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-26-000047 |
| 2026-05-07 | 16:01 ET | [10-Q](/filings/0001567264-26-000046.md) | Quarterly report, period 2026-03-31 | 0001567264-26-000046 |
| 2026-04-30 | 16:06 ET | [DEF 14A](/filings/0001567264-26-000035.md) | Proxy statement, period 2026-04-30 | 0001567264-26-000035 |
| 2026-03-27 | 16:13 ET | [8-K](/filings/0001567264-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-26-000025 |
| 2026-03-27 | 16:01 ET | [10-K](/filings/0001567264-26-000024.md) | Annual report, period 2025-12-31 | 0001567264-26-000024 |
| 2026-03-23 | 16:02 ET | [8-K](/filings/0001567264-26-000021.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-26-000021 |
| 2026-03-06 | 08:04 ET | [8-K](/filings/0001567264-26-000014.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-26-000014 |
| 2026-03-05 | 08:07 ET | [8-K](/filings/0001567264-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-26-000011 |
| 2026-02-13 | 16:00 ET | [8-K](/filings/0001567264-26-000007.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-26-000007 |
| 2025-12-05 | 07:33 ET | [8-K](/filings/0001567264-25-000111.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001567264-25-000111 |
| 2025-12-04 | 07:02 ET | [8-K](/filings/0001567264-25-000109.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-25-000109 |
| 2025-11-06 | 16:04 ET | [8-K](/filings/0001567264-25-000104.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-25-000104 |
| 2025-11-06 | 16:01 ET | [10-Q](/filings/0001567264-25-000103.md) | Quarterly report, period 2025-09-30 | 0001567264-25-000103 |
| 2025-10-31 | 16:54 ET | [8-K](/filings/0001628280-25-047855.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-047855 |
| 2025-10-23 | 16:02 ET | [8-K](/filings/0001567264-25-000096.md) | 5.07 Shareholder vote results | 0001567264-25-000096 |
| 2025-09-10 | 16:04 ET | [8-K](/filings/0001567264-25-000093.md) | 8.01 Other events | 0001567264-25-000093 |
| 2025-09-09 | 08:37 ET | [DEF 14A](/filings/0001567264-25-000090.md) | Proxy statement, period 2025-09-09 | 0001567264-25-000090 |
| 2025-08-12 | 16:33 ET | [8-K](/filings/0001567264-25-000081.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-25-000081 |
| 2025-08-07 | 16:09 ET | [8-K](/filings/0001567264-25-000078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-25-000078 |
| 2025-08-07 | 16:01 ET | [10-Q](/filings/0001567264-25-000077.md) | Quarterly report, period 2025-06-30 | 0001567264-25-000077 |
| 2025-08-04 | 16:01 ET | [8-K](/filings/0001567264-25-000071.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-25-000071 |
| 2025-07-18 | 16:18 ET | [8-K](/filings/0001567264-25-000069.md) | 5.07 Shareholder vote results | 0001567264-25-000069 |
| 2025-06-13 | 16:10 ET | [8-K](/filings/0001628280-25-031311.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-031311 |
| 2025-06-06 | 17:05 ET | [8-K](/filings/0001567264-25-000056.md) | 3.01 Delisting notice | 0001567264-25-000056 |
| 2025-06-02 | 16:01 ET | [DEF 14A](/filings/0001567264-25-000050.md) | Proxy statement, period 2025-06-02 | 0001567264-25-000050 |
| 2025-05-20 | 16:05 ET | [8-K](/filings/0001567264-25-000042.md) | 3.01 Delisting notice | 0001567264-25-000042 |
| 2025-05-13 | 16:08 ET | [8-K](/filings/0001567264-25-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-25-000040 |
| 2025-05-13 | 16:01 ET | [10-Q](/filings/0001567264-25-000039.md) | Quarterly report, period 2025-03-31 | 0001567264-25-000039 |
| 2025-04-25 | 17:24 ET | [8-K](/filings/0001628280-25-020057.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-020057 |
| 2025-04-24 | 08:01 ET | [S-1/A](/filings/0001628280-25-019491.md) | Registration statement, amended | 0001628280-25-019491 |
| 2025-04-23 | 20:12 ET | [8-K](/filings/0001628280-25-018908.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-018908 |
| 2025-04-22 | 17:23 ET | [S-1](/filings/0001628280-25-018892.md) | Registration statement | 0001628280-25-018892 |
| 2025-03-13 | 16:09 ET | [8-K](/filings/0001567264-25-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-25-000011 |
| 2025-03-13 | 16:03 ET | [10-K](/filings/0001567264-25-000010.md) | Annual report, period 2024-12-31 | 0001567264-25-000010 |
| 2024-12-13 | 16:00 ET | [S-1](/filings/0001628280-24-051180.md) | Registration statement | 0001628280-24-051180 |
| 2024-11-22 | 21:43 ET | [8-K](/filings/0001628280-24-048910.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-048910 |
| 2024-11-13 | 16:10 ET | [8-K](/filings/0001567264-24-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-24-000053 |
| 2024-11-13 | 16:01 ET | [10-Q](/filings/0001567264-24-000052.md) | Quarterly report, period 2024-09-30 | 0001567264-24-000052 |
| 2024-10-23 | 16:20 ET | [8-K](/filings/0001567264-24-000045.md) | 5.02 Departure or appointment of officers or directors | 0001567264-24-000045 |
| 2024-08-08 | 16:22 ET | [8-K](/filings/0001567264-24-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-24-000042 |
| 2024-08-08 | 16:12 ET | [10-Q](/filings/0001567264-24-000041.md) | Quarterly report, period 2024-06-30 | 0001567264-24-000041 |
| 2024-07-17 | 16:01 ET | [8-K](/filings/0001567264-24-000035.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001567264-24-000035 |
| 2024-07-03 | 16:08 ET | [8-K](/filings/0001628280-24-031098.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-24-031098 |
| 2024-06-04 | 16:05 ET | [DEF 14A](/filings/0001567264-24-000031.md) | Proxy statement, period 2024-06-04 | 0001567264-24-000031 |
| 2024-05-24 | 16:00 ET | [8-K](/filings/0001567264-24-000021.md) | 5.02 Departure or appointment of officers or directors | 0001567264-24-000021 |
| 2024-05-15 | 16:25 ET | [8-K](/filings/0001567264-24-000017.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001567264-24-000017 |
| 2024-05-10 | 16:00 ET | [8-K](/filings/0001567264-24-000013.md) | 1.01 Entry into a material agreement | 0001567264-24-000013 |

Page 1 of 2. [Older](/companies/ints/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.